NCT06889428View on ClinicalTrials.gov

Prognostic Significance of CMR-Confirmed Infarct in MINOCA Patients from Sweden and Australia

CompletedOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
MINOCA
Interventions
DIAGNOSTIC_TEST

CMR

No CMR

Trial Locations (1)

5005

University of Adelaide, Adelaide

All Listed Sponsors
collaborator

Uppsala University

OTHER

lead

University of Adelaide

OTHER

NCT06889428 - Prognostic Significance of CMR-Confirmed Infarct in MINOCA Patients from Sweden and Australia | Biotech Hunter | Biotech Hunter